Evidence map›Paper›PMID 32103439›Full record

Trial reportNeurocritical care2021

Effect of Locally Delivered Nimodipine Microparticles on Spreading Depolarization in Aneurysmal Subarachnoid Hemorrhage.

Andrew P Carlson, Amal Alchbli, Daniel Hänggi, R Loch Macdonald, C William Shuttleworth

Abstract readClinical Trial, Phase III
PubMed Publisher
In one paragraph

Trial report in Neurocritical care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Synaptic ZnNeurobiology of disease · 2024
    Article
  6. Article
  7. Synaptic ZnbioRxiv : the preprint server for biology · 2023
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrew P CarlsonDepartment of Neurosurgery, University of New Mexico School of Medicine, 1UNM, Albuquerque, NM, 87131, USA. Andrewcarlson@salud.unm.edu.ORCID http://orcid.org/0000-0003-2189-3699
Amal AlchbliDepartment of Neurosurgery, University of New Mexico School of Medicine, 1UNM, Albuquerque, NM, 87131, USA.
Daniel HänggiDepartment of Neurosurgery, University Medical Center Mannheim, Ruprecht-Karls-University Heidelberg, Mannheim, Germany.
R Loch MacdonaldDepartment of Neurosurgery, University of California San Francisco Fresno, Fresno, USA.
C William ShuttleworthDepartment of Neuroscience, University of New Mexico School of Medicine, Albuquerque, USA.

Funding

University of New Mexico (UNM) Center for Brain Recovery and RepairP20GM109089 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI SHUTTLEWORTH, CLAUDE W · 2015 to 2024
$22.7M
6 · The paper itself

Abstract

backgroundRecurrent spreading depolarizations (SDs) occur in patients after aneurysmal subarachnoid hemorrhage (aSAH), resulting in metabolic stress to brain. These events are closely associated with delayed cerebral ischemia. Preclinical data suggest that the beneficial effect of nimodipine demonstrated in clinical trials may be related to inhibition of SD rather than limitation of large artery vasospasm.

methodsSubjects enrolled in a phase 3 trial of intraventricularly delivered, sustained-release nimodipine (EG-1962) versus standard of care oral nimodipine (NEWTON 2) who required surgical clipping had subdural strip electrodes implanted for monitoring of SD. SD was then scored blinded to NEWTON 2 allocation.

resultsFive subjects underwent electrocorticography monitoring of SD. Three of five patients had SD. There were fewer SDs, a lower rate of SD, and shorter depression durations in subjects treated with EG-1962 compared to standard of care. Outcomes were worse in the standard of care group, though there were baseline imbalances.

conclusionsThese results are consistent with a beneficial effect of locally delivered nimodipine (EG-1962) on SD after aSAH in more severely injured patients who are at risk of delayed cerebral ischemia related to SD. Larger studies are warranted to test this effect.

Indexed as

Brain IschemiaSubarachnoid HemorrhageVasospasm, IntracranialBrainElectrocorticographyHumansNimodipineNimodipineAneurysmal subarachnoid hemorrhageDelayed cerebral ischemiaNimodipineSpreading depolarizationVasospasm

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.